Study on protection against M. tuberculosis of Ag85a-recombinant BCG vaccine
Because of such limitations, public health experts and physicians have long seen a need for alternatives to the traditional BCG vaccine and current treatment strategies.
Construction and identification of esat6 recombinant BCG vaccine
Therapeutic effects of murine Ipr1 recombinant BCG vaccine on Mycobacterium tuberculosis infection in murine model
This paper reports our investigation of the possibility of the ultiliza- tion of the Bioluminesceht (BL) technique to substitute the traditional viability count of CFU of current BCG vaccine.
It indicated that the small dosage inactivated BCG vaccine could improve the damaged cellular immune function.
Detection of the tuberculosis sign was carried out in 62 children vaccinated with BCG vaccine, and tuberculin tests were made at the same time.
The BCG vaccine prevents severe forms of TB in children, such as TB meningitis.
Advances in recombinant BCG vaccine against echinococcosis
GACVS supports the -recent WHO initiative to further characterize BCG strains, which will help systematic differentiation of BCG vaccines in terms of safety and efficacy.
The Sabin oral antipolio vaccine and the BCG vaccine against tuberculosis are examples of this type of vaccine.
To explore the curative effect of Maozhaocao capsule in treating armpit lymph gland reaction among babies after injected BCG vaccine.
Tetrazolium salt assay for rapid determination of viable count of BCG vaccine